David Sterman has worked as an investment analyst for nearly two decades. He started his Wall Street career in equity research at Smith Barney, culminating in a position as Senior Analyst covering European banks. While at Smith Barney, he learned of all the tricks used by Wall Street to steer the best advice to their top clients and their own trading desk.
David has also served as Managing Editor at TheStreet.com and Director of Research at Individual Investor. In addition, David worked as Director of Research for Jesup & Lamont Securities. David has made numerous media appearances over the years, primarily on CNBC and Bloomberg TV, and has a master's degree in management from Georgia Tech.
David Stermanon
Analyst Articles
Just like the broader economy, various industries go through phases of retrenchment, growth and then a peak. If you hold off on investing in these cyclical industries until growth is robust, then you’ve missed the boat. Various studies indicate that stock prices peak about… Read More
When there’s a recession or when the economy is sluggish like now, consumers look for ways to save their hard-earned money anyway they can. They can do so… Read More
Even as investors spent much of the last decade licking their wounds with U.S. investments after the dot-com bubble was pricked, there were still solid gains to be had for investors willing to venture abroad. Indeed, the concept of BRIC (Brazil, Russia, India and China) investing was a savvy play… Read More
Nick Dreystadt is an Unsung Hero of American business. In 1933, the engineer knocked on the boardroom door at General Motors (NYSE: GM) and asked to be heard for ten minutes. He said he could take GM’s most problematic division and make it profitable within 18 months. Read More
Anyone waiting for Big Pharma to stumble on the industry’s so-called “patent cliff” has been heartily disappointed. In spite of many high-revenue products facing patent expirations in the next few years, the group continues to be a top performer, lifting the health care sector to a market-beating 9% gain by… Read More
In the face of a tough second-quarter economy, these two portfolio holdings managed just fine. Here’s why looking out a year or two, these businesses should really flourish… It is purely coincidental that two of my favorite companies delivered decent second-quarter results on the… Read More
There is no question that Warren Buffett has had a great run as an investor and money manager. His ability to spot great deals and hold companies through thick and thin is… Read More
At the height of the dot-com era, with the Nasdaq trading at 5,000, the airwaves were filled with predictions of even bigger gains to come. One prediction that called for “Dow 36,000” was a sure sign that stocks were headed for trouble. Bubbles get pricked right at the time of… Read More
Most successful investors figure out ways to spot opportunity before the masses figure it out. They often get in early — before the crowd catches on and sends the stock price up — and reap large benefits along the way. And… Read More
This is not your grandmother’s market. You can’t invest in blue chips like Procter and Gamble (NYSE: PG) or Johnson & Johnson (NYSE: JNJ) and expect to receive the same dividend yields of 5%… Read More
